Large-scale testing (Phase 3)Study completedNCT01448707
What this trial is testing
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionsAcquired Immunodeficiency Syndrome (AIDS) Virus
Janssen-Cilag International NV 274